Male-to-female (MTF) transgender individuals typically undergo hormone therapy to introduce female hormones and suppress male hormone levels. The primary hormones used for MTF hormone therapy are estrogen and anti-androgens.
Here’s an overview of how these hormones are used in the transition process:
⦁ Estrogen: Estrogen is the primary female sex hormone responsible for the development of feminine secondary sexual characteristics. It promotes the growth of breast tissue, softens the skin, redistributes body fat to a more feminine pattern (such as in the hips and thighs), and decreases muscle mass.
⦁ Anti-androgens: Anti-androgens are medications that block or reduce the effects of male hormones (androgens, primarily testosterone) in the body. By suppressing testosterone levels, anti-androgens help to counteract the development of masculine features and facilitate the feminization process.
The specific medications and dosages used in MTF hormone therapy may vary depending on individual factors such as age, overall health, medical history, and response to treatment. Hormone therapy is typically administered through oral pills, patches, gels, or injections.
It’s important to note that hormone therapy is a gradual process, and the physical changes brought about by hormones may take several months to become noticeable. Additionally, the effects of hormone therapy can vary from person to person, and not all changes are reversible if the therapy is discontinued.
Hormone therapy for transgender individuals should always be conducted under the supervision and guidance of qualified healthcare professionals who specialize in transgender healthcare. They will monitor hormone levels and adjust the treatment plan to ensure safety and effectiveness throughout the transition process. Regular check-ups and ongoing medical supervision are essential for the well-being and health of individuals undergoing hormone therapy.